GlassScriptPhysician profile
Zinon Pappas
NPI 1689645855
$283.88
in general payments reported to CMS, 2019-2025
11 companies · $17.49 in 2025
The $17.49 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.08 · 2020: $78.57 · 2022: $13.50 · 2024: $96.24 · 2025: $17.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $113.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $71.04 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Zimmer Biomet Holdings, INC. | $37.21 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.96 | 2019-2020 | |
| Depuy Synthes Sales INC. | $25.87 | 2019-2022 | |
| Chiesi USA, INC. | $25.25 | 2020 | |
| Bioventus LLC | $25.20 | 2024 | Exogen Ultrasound Bone Healing System |
| Sanofi-Aventis U.S. LLC | $19.00 | 2019 | |
| Collegium Pharmaceutical, INC. | $17.49 | 2025 | Belbuca |
| Biodelivery Sciences International, INC. | $15.02 | 2019 | |
| Daiichi Sankyo INC. | $10.52 | 2019 | |
| Fidia Pharma USA INC. | $8.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zinon Pappas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.